Crossref
TCT-22 Long-Term Antiplatelet Monotherapy After PCI in Acute Coronary Syndrome: Clopidogrel Versus Aspirin
JACC · 2026-11 · 88 (18) · B9
DOI: 10.1016/j.jacc.2026.09.062 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-11. Verfasst von Hao-Yu Wang und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, H., Cheng, J., & Dou, K. (2026). TCT-22 Long-Term Antiplatelet Monotherapy After PCI in Acute Coronary Syndrome: Clopidogrel Versus Aspirin. JACC, 88(18), B9. https://doi.org/10.1016/j.jacc.2026.09.062
Vancouver
Wang H, Cheng J, Dou K. TCT-22 Long-Term Antiplatelet Monotherapy After PCI in Acute Coronary Syndrome: Clopidogrel Versus Aspirin. JACC. 2026;88(18):B9. doi:10.1016/j.jacc.2026.09.062
BibTeX
@article{Wang2026,
author = {Wang, Hao-Yu and Cheng, Jiaxi and Dou, Kefei},
title = {TCT-22 Long-Term Antiplatelet Monotherapy After PCI in Acute Coronary Syndrome: Clopidogrel Versus Aspirin},
journal = {JACC},
year = {2026},
volume = {88},
number = {18},
pages = {B9},
doi = {10.1016/j.jacc.2026.09.062}
}
EUVIMED